10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tumor suppressor protein p19(ARF) (Arf; p14(ARF) in humans) functions in both p53-dependent and -independent modes to counteract hyper-proliferative signals caused by proto-oncogene activation, but its p53-independent activities remain poorly understood. Using the tandem affinity purification-tag technique, we purified Arf-containing protein complexes and identified p68 DEAD-box protein (DDX5) as a novel interacting protein of Arf. In this study, we found that DDX5 interacts with c-Myc, and harbors essential roles for c-Myc-mediated transcription and its transforming activity. Furthermore, when c-Myc was forcibly expressed, the expression level of DDX5 protein was drastically increased through the acceleration of protein synthesis of DDX5, suggesting the presence of an oncogenic positive feedback loop including c-Myc and DDX5. Strikingly, Arf blocked the physical interaction between DDX5 and c-Myc, and drove away DDX5 from the promoter of c-Myc target genes. These observations most likely indicate the mechanism by which Arf causes p53-independent tumor-suppressive activity.

          Related collections

          Author and article information

          Journal
          Oncogene
          Oncogene
          Springer Nature America, Inc
          1476-5594
          0950-9232
          Jan 15 2015
          : 34
          : 3
          Affiliations
          [1 ] Division of Structural Biochemistry, Department of Biochemistry, School of Medicine, Jichi Medical University, Shimotsuke-shi, Japan.
          [2 ] Faculty of Pharmacy, Department of Biochemistry, Keio University, Minato-ku, Japan.
          [3 ] Laboratory of Signal Transduction, Department of Cell Biology, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Japan.
          [4 ] Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Shimotsuke-shi, Japan.
          [5 ] Department of Surgery, Saitama Medical Center, Jichi Medical University, Omiya-ku, Japan.
          Article
          onc2013561
          10.1038/onc.2013.561
          24469041
          15ae431b-1cc9-4673-83b6-d9954ecb252a
          History

          Comments

          Comment on this article